AP3M2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.297400E-01
Normal-vs-Stage2
6.958400E-01
Normal-vs-Stage3
5.929600E-01
Normal-vs-Stage4
3.562600E-01
Stage1-vs-Stage2
4.574000E-01
Stage1-vs-Stage3
2.129200E-01
Stage1-vs-Stage4
8.274400E-01
Stage2-vs-Stage3
3.194600E-01
Stage2-vs-Stage4
7.190400E-01
Stage3-vs-Stage4
1.892600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.063400E-01
Normal-vs-AfricanAmerican
6.153400E-01
Normal-vs-Asian
4.323400E-01
Caucasian-vs-AfricanAmerican
2.470300E-02
Caucasian-vs-Asian
7.503600E-01
AfricanAmerican-vs-Asian
1.277360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.227800E-01
Normal-vs-Female
8.159800E-01
Male-vs-Female
1.012590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.273400E-01
Normal-vs-Age(41-60Yrs)
4.082200E-01
Normal-vs-Age(61-80Yrs)
8.496000E-01
Normal-vs-Age(81-100Yrs)
6.376800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.931200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.712800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.600800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.078200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.226000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.211800E-01
Normal-vs-Daily Drinker
9.598000E-01
Normal-vs-Weekly Drinker
5.917200E-01
Normal-vs-Occasional Drinker
5.165600E-01
Normal-vs-Social Drinker
8.663400E-01
Non Drinker-vs-Daily Drinker
4.996800E-01
Non Drinker-vs-Weekly Drinker
9.553800E-01
Non Drinker-vs-Occasional Drinker
6.142400E-01
Non Drinker-vs-Social Drinker
6.488000E-01
Daily Drinker-vs-Weekly Drinker
5.361800E-01
Daily Drinker-vs-Occasional Drinker
2.576600E-01
Daily Drinker-vs-Social Drinker
8.609600E-01
Weekly Drinker-vs-Occasional Drinker
5.702600E-01
Weekly Drinker-vs-Social Drinker
6.339000E-01
Occasional Drinker-vs-Social Drinker
3.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.519200E-01
Normal-vs-Grade 2
1.171760E-01
Normal-vs-Grade 3
1.218800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.898300E-02
Grade 1-vs-Grade 3
1.959660E-02
Grade 1-vs-Grade 4
3.519200E-01
Grade 2-vs-Grade 3
1.109240E-01
Grade 2-vs-Grade 4
1.171760E-01
Grade 3-vs-Grade 4
1.218800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.639600E-01
Normal-vs-NonDiabetic
6.067400E-01
Diabetic-vs-NonDiabetic
1.290040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.624000E-01
Normal-vs-NoPancreatitis
7.204000E-01
Pancreatitis-vs-NoPancreatitis
9.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.520800E-01
Normal-vs-N1
7.064200E-01
N0-vs-N1
9.347000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.250800E-01
Normal-vs-TP53-NonMutant
9.277200E-01
TP53-Mutant-vs-TP53-NonMutant
1.617540E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
